Compare LAND & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAND | MRVI |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.0M | 449.6M |
| IPO Year | 2013 | 2020 |
| Metric | LAND | MRVI |
|---|---|---|
| Price | $8.97 | $3.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.58 |
| AVG Volume (30 Days) | 388.0K | ★ 1.4M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 6.24% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $67,936,000.00 | ★ $192,435,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.36 | $9.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.47 | $1.67 |
| 52 Week High | $11.93 | $6.21 |
| Indicator | LAND | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 39.27 | 54.97 |
| Support Level | $9.05 | $3.60 |
| Resistance Level | $9.28 | $3.95 |
| Average True Range (ATR) | 0.13 | 0.18 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 9.52 | 50.39 |
Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.